Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;18(2):175-205.
doi: 10.2174/1389202917666160803165229.

Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression

Affiliations
Review

Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression

Edward A Ratovitski. Curr Genomics. 2017 Apr.

Abstract

Accumulating evidence shows that hallmarks of cancer include: "genetic and epigenetic alterations leading to inactivation of cancer suppressors, overexpression of oncogenes, deregulation of intracellular signaling cascades, alterations of cancer cell metabolism, failure to undergo cancer cell death, induction of epithelial to mesenchymal transition, invasiveness, metastasis, deregulation of immune response and changes in cancer microenvironment, which underpin cancer development". Natural compounds as bioactive ingredients isolated from natural sources (plants, fungi, marine life forms) have revolutionized the field of anticancer therapeutics and rapid developments in preclinical studies are encouraging. Natural compounds could affect the epigenetic molecular mechanisms that modulate gene expression, as well as DNA damage and repair mechanisms. The current review will describe the latest achievements in using naturally produced compounds targeting epigenetic regulators and modulators of gene transcription in vitro and in vivo to generate novel anticancer therapeutics.

Keywords: Chromatin; DNA methylation; Epigenetics; Histone acetylation; Histone methylation; Natural compounds; Tumorigenesis; microRNA.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 2000;100:57–70. - PubMed
    1. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. - PubMed
    1. Floor S.L., Dumont J.E., Maenhaut C., Raspe E. Hallmarks of cancer: of all cancer cells, all the time? Trends Mol. Med. 2012;18:509–515. - PubMed
    1. Plass C., Pfister S.M., Lindroth A.M., Bogatyrova O., Claus R., Lichter P. Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat. Rev. Genet. 2013;14(11):765–780. - PubMed
    1. Lichtenstein A.V. Cancer: evolutionary, genetic and epigenetic aspects. Clin. Epigenetics. 2010;1:85–100. - PMC - PubMed